financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Advanced Micro Devices, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Advanced Micro Devices, Inc.
May 1, 2024 4:48 AM

07:20 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target at $200, on P/E of 36.8x our '25 EPS view, below 5-year historical average/above peers. We adjust our '24 EPS estimate to $3.54 from $4.10 but keep '25 at $5.44. AMD posts Q1 EPS of $0.62 vs. $0.60, beating the $0.61 consensus. Sales rose 2% and provided Q2 outlook (+6% Y/Y) largely in line with expectations, as investors were hoping for more amid a strong AI capex environment. Still, Data Center momentum (+80%) remains strong, as it incrementally boosts '24 GPU server outlook ($4B from $3.5B) given better MI300X visibility from cloud players (Microsoft, Meta, Oracle) and enterprise momentum. Easy comparisons and PC recovery drove Client (+85%), while we expect an enterprise refresh cycle for AI PCs to start in the 2H. Lower Embedded (-46%) and Gaming (-48%) demand remain headwinds but will alleviate in the 2H. AMD remains a sharetaker on the server CPU side (at the expense of Intel) while gross margin expanded by 230 basis points to 52%, on better mix. Net cash stands at $4.2B.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Understanding Section 7702 plans
Understanding Section 7702 plans
Jun 11, 2024
Key takeaways Section 7702 of the IRS tax code outlines the criteria that life insurance policies must meet to qualify for tax advantages. The term '7702 plan' is a loose marketing term, not a specific type of life insurance policy. It typically refers to the tax treatment of cash value life insurance policies, which can include whole, universal, variable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved